PNC Financial Services Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,692
| Closed | -$294K | – | 4917 |
|
|
2022
Q3 | $294K | Sell |
5,692
-3,273
| -37% | -$135K | ﹤0.01% | 1845 |
|
|
2022
Q2 | $222K | Buy |
8,965
+1,470
| +20% | +$32.4K | ﹤0.01% | 2077 |
|
|
2022
Q1 | $188K | Buy |
7,495
+4,599
| +159% | +$129K | ﹤0.01% | 2311 |
|
|
2021
Q4 | $105K | Buy |
2,896
+2,778
| +2,354% | +$97.5K | ﹤0.01% | 2658 |
|
|
2021
Q3 | $2K | Buy |
118
+93
| +372% | +$1.45K | ﹤0.01% | 4165 |
|
|
2021
Q2 | $0 | Sell |
25
-17
| -40% | -$419 | ﹤0.01% | 4335 |
|
|
2021
Q1 | $2K | Hold |
42
| – | – | ﹤0.01% | 3992 |
|
|
2020
Q4 | $3K | Buy |
42
+28
| +200% | +$1.6K | ﹤0.01% | 3812 |
|
|
2020
Q3 | $1K | Buy |
14
+6
| +75% | +$323 | ﹤0.01% | 3896 |
|
|
2020
Q2 | $0 | Buy |
+8
| New | +$435 | ﹤0.01% | 4105 |
|
|
2020
Q1 | – | Sell |
-74
| Closed | -$3K | – | 4122 |
|
|
2019
Q4 | $3K | Hold |
74
| – | – | ﹤0.01% | 3755 |
|
|
2019
Q3 | $1K | Hold |
74
| – | – | ﹤0.01% | 3955 |
|
|
2019
Q2 | $1K | Hold |
74
| – | – | ﹤0.01% | 3975 |
|
|
2019
Q1 | $1K | Hold |
74
| – | – | ﹤0.01% | 3989 |
|
|
2018
Q4 | $1K | Hold |
74
| – | – | ﹤0.01% | 3999 |
|
|
2018
Q3 | $1K | Hold |
74
| – | – | ﹤0.01% | 4077 |
|
|
2018
Q2 | $1K | Sell |
74
-219,747
| -100% | -$2.63M | ﹤0.01% | 4095 |
|
|
2018
Q1 | $2.99M | Buy |
+219,821
| New | +$2.27M | ﹤0.01% | 897 |
|
|
2016
Q3 | – | Sell |
-166
| Closed | -$1K | – | 4359 |
|
|
2016
Q2 | $1K | Sell |
166
-7
| -4% | -$26 | ﹤0.01% | 4409 |
|
|
2016
Q1 | $0 | Sell |
173
-11,034
| -98% | -$40.2K | ﹤0.01% | 4602 |
|
|
2015
Q4 | $91K | Hold |
11,207
| – | – | ﹤0.01% | 2506 |
|
|
2015
Q3 | $67K | Sell |
11,207
-1,194
| -10% | -$8.63K | ﹤0.01% | 2740 |
|
|
2015
Q2 | $101K | Buy |
12,401
+161
| +1% | +$1.28K | ﹤0.01% | 2640 |
|
|
2015
Q1 | $92K | Hold |
12,240
| – | – | ﹤0.01% | 2742 |
|
|
2014
Q4 | $84K | Sell |
12,240
-2,000
| -14% | -$10.6K | ﹤0.01% | 2568 |
|
|
2014
Q3 | $64K | Hold |
14,240
| – | – | ﹤0.01% | 2582 |
|
|
2014
Q2 | $84K | Sell |
14,240
-40
| -0.3% | -$225 | ﹤0.01% | 2362 |
|
|
2014
Q1 | $94K | Buy |
+14,280
| New | +$99.2K | ﹤0.01% | 2242 |
|
Other funds holding CCXI
PNC Financial Services Group's CCXI Position: Q4 2022 in Review
PNC Financial Services Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 5,692 shares — an estimated $294K sold.
PNC Financial Services Group first reported a position in CCXI in Q1 2014 and held it in 28 quarters. The position peaked at $2.99M in Q1 2018. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- PNC Financial Services Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- PNC Financial Services Group sold 5,692 ChemoCentryx, Inc. shares in Q4 2022, an estimated $294K.
- PNC Financial Services Group first reported a position in ChemoCentryx, Inc. in Q1 2014 and held it in 28 quarters.
- PNC Financial Services Group's ChemoCentryx, Inc. position peaked at $2.99M in Q1 2018.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.